Live Price
Live Volume
ImmunityBio Market Segments
Overnight
*No Trades in Segment
After Hours
| Open | $8.40 |
|---|---|
| Close | $8.41 |
| Low | $8.37 |
| Low Change | -0.03 (-0.36%) |
| High | $8.44 |
| High Change | +0.04 (+0.53%) |
| Range | $0.07 |
| Volume | 706.224K |
| Dollar Volume | $5.94M |
Regular Trading Hours
| Open | $8.21 |
|---|---|
| Close | $8.40 |
| Low | $8.18 |
| Low Change | -0.03 (-0.37%) |
| High | $8.76 |
| High Change | +0.55 (+6.70%) |
| Range | $0.58 |
| Volume | 11.491M |
| Dollar Volume | $96.46M |
Premarket
| Open | $8.32 |
|---|---|
| Close | $8.20 |
| Low | $8.20 |
| Low Change | -0.12 (-1.45%) |
| High | $8.32 |
| High Change | +0.00 (+0.00%) |
| Range | $0.12 |
| Volume | 104.02K |
| Dollar Volume | $852.96K |
After Hours Yesterday
| Open | $8.25 |
|---|---|
| Close | $8.25 |
| Low | $8.21 |
| Low Change | -0.04 (-0.48%) |
| High | $8.26 |
| High Change | +0.01 (+0.12%) |
| Range | $0.05 |
| Volume | 562.712K |
| Dollar Volume | $4.64M |
Regular Trading Hours Yesterday
| Open | $8.18 |
|---|---|
| Close | $8.24 |
| Low | $8.07 |
| Low Change | -0.11 (-1.34%) |
| High | $8.40 |
| High Change | +0.22 (+2.69%) |
| Range | $0.33 |
| Volume | 8.442M |
| Dollar Volume | $69.57M |
Premarket Yesterday
| Open | $8.16 |
|---|---|
| Close | $8.18 |
| Low | $8.15 |
| Low Change | -0.01 (-0.12%) |
| High | $8.24 |
| High Change | +0.08 (+0.98%) |
| Range | $0.09 |
| Volume | 138.025K |
| Dollar Volume | $1.13M |
ImmunityBio News
1 month agoinvesting.comImmunityBio stock jumps on UAE drug approval for ANKTIVA
3 months agoinvesting.comImmunityBio stock gains on five new U.S. patent awards
4 months agobenzinga.comWhy ImmunityBio Stock Is Surging On Wednesday?
5 months agoinvesting.comImmunityBio stock rises after FDA compliance response
5 months agoinvesting.comImmunityBio stock surges on $100M financing deal
5 months agoinvesting.comImmunityBio shares plunge after FDA warning over misleading ads
5 months agoinvesting.comImmunityBio stock tumbles after FDA warning on misleading ads
6 months agoinvesting.comImmunityBio stock soars after EU authorization for bladder cancer therapy
6 months agoinvesting.comImmunityBio stock rises after productive regulatory talks with Saudi FDA
7 months agoinvesting.comImmunityBio stock soars after FDA meeting on bladder cancer treatment
ImmunityBio Top Trades
ImmunityBio's top trade so far today returned +6.83%, while the top short trade returned -4.45%.
ImmunityBio Moving Averages
| 5 Day Moving Average (SMA5) | $7.93 |
|---|---|
| 10 Day Moving Average (SMA10) | $7.86 |
| 20 Day Moving Average (SMA20) | $7.62 |
| 50 Day Moving Average (SMA50) | $7.78 |
| 100 Day Moving Average (SMA100) | $7.66 |
| 200 Day Moving Average (SMA200) | $6.39 |
ImmunityBio Statistics
| Average Volume (30 Days) | 8.55M |
|---|---|
| P/E Ratio (Current) | -8.71 |
| EPS (Current) | -$0.94 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$288.07M |
| Cash Ratio | 0.99 |
| Current Ratio | 5.72 |
| Quick Ratio | 5.70 |
| Debt to Equity | -0.40 |
| Enterprise Value | $9.02B |
| EV to EBITDA | -38.35 |
| EV to Sales | 54.40 |
| Price to Book | -8.29 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 52.36 |
| Return on Assets | -1.58% |
| Return on Equity | 0.95% |
ImmunityBio Stock Splits
There have been no stock splits for ImmunityBio (IBRX).
ImmunityBio Dividends
There have been no dividends for ImmunityBio (IBRX).